HTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...
Read moreThe UK will continue to adopt decisions taken by the European Commission on the approval of new mark...
Read moreTo facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...
Read moreA survey of employees within pricing and market access n pharma and biotech companies.
Read moreThe SMC has recently announced that it is beginning to restart its medicines appraisal process in a ...
Read moreWithout a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...
Read moreNICE has announced they will begin a phased restart of publishing guidance, whilst SMC meetings are ...
Read moreWe received fabulous feedback, with responses from at least 15 industry executives across global pha...
Read moreWhilst many businesses are currently working remotely, up-skilling your workforce through interactiv...
Read moreGiven the shutdown occurring in response to COVID-19, payers and HTA bodies are struggling to adjust...
Read more